iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Strong Trading Volume – Here’s What Happened

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) saw strong trading volume on Thursday . Approximately 568,917 shares changed hands during trading, an increase of 426% from the previous session’s volume of 108,206 shares.The stock last traded at $100.09 and had previously closed at $98.29.

iShares U.S. Pharmaceuticals ETF Price Performance

The stock has a market cap of $1.14 billion, a price-to-earnings ratio of 17.75 and a beta of 0.49. The stock’s 50-day moving average is $91.69 and its 200 day moving average is $88.76.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

A number of institutional investors have recently modified their holdings of the business. EFG International AG acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter worth $38,000. Assetmark Inc. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 203.9% during the fourth quarter. Assetmark Inc. now owns 465 shares of the company’s stock worth $39,000 after buying an additional 312 shares in the last quarter. O Shaughnessy Asset Management LLC boosted its holdings in iShares U.S. Pharmaceuticals ETF by 35.0% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock worth $39,000 after buying an additional 120 shares in the last quarter. Blueline Advisors LLC acquired a new position in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth about $41,000. Finally, Ameriflex Group Inc. grew its position in iShares U.S. Pharmaceuticals ETF by 100.0% during the third quarter. Ameriflex Group Inc. now owns 582 shares of the company’s stock worth $42,000 after buying an additional 291 shares during the period.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.